Wednesday, October 28, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Pancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review

Diabetes, metabolic syndrome and obesity : targets and therapy · 2026 · Kutsyba T, Raj S, van der Berg M et

MH
By Maren Holt · Senior Reporter, GLP-1

From the source

Pancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review

Diabetes, metabolic syndrome and obesity : targets and therapy · 2026 · Kutsyba T, Raj S, van der Berg M et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →